|
[1]
|
Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002;18(4):295 − 307. https://doi.org/10.1089/088922202753472874CrossRef
|
|
[2]
|
Duong YT, Qiu MF, De AK, Jackson K, Dobbs T, Kim AA, et al. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS One 2012;7(3):e33328. https://doi.org/10.1371/journal.pone.0033328CrossRef
|
|
[3]
|
Persaud D, Gay H, Ziemniak C, Chen YH, Piatak Jr M, Chun TW, et al. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med 2013;369(19):1828 − 35. https://doi.org/10.1056/NEJMoa1302976CrossRef
|
|
[4]
|
WHO. Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus. 2022. https://www.who.int/publications/i/item/9789240039360. [2023-12-1] |
|
[5]
|
Dobbs T, Liu X, Anderson R, Nkengasong J, Parekh BS. A comprehensive evaluation of the proficiency testing program for the HIV-1 BED incidence assay. J Clin Microbiol 2011;49(10):3470 − 3. https://doi.org/10.1128/jcm.01122-11CrossRef
|
|
[6]
|
Di Y, Meng TT, Jing YY, Liu XW, Duan LJ, Jiang Y, et al. Development of a recombinant antigen for capture enzyme immunoassay to detect recent HIV-1 infection. Chin J AIDS STD 2019;25(6):552 − 5,558. https://doi.org/10.13419/j.cnki.aids.2019.06.02CrossRef
|
|
[7]
|
UNAIDS, WHO. Using recency assays for HIV surveillance — 2022 technical guidance. 2023. https://www.unaids.org/en/resources/documents/2023/using-recency-assays-HIV-surveillance. [2023-12-1] |
|
[8]
|
Chinese Center for Disease Control and Prevention. National guideline for detection of HIV/AIDS. 2015. https://ncaids.chinacdc.cn/fzyw_10256/jsgf/201608/t20160810_133524.htm. (In Chinese). [2023-12-1] |
|
[9]
|
Parekh BS, Hanson DL, Hargrove J, Branson B, Green T, Dobbs T, et al. Determination of mean recency period for estimation of HIV type 1 incidence with the BED-capture EIA in persons infected with diverse subtypes. AIDS Res Hum Retroviruses 2011;27(3):265 − 73. https://doi.org/10.1089/aid.2010.0159CrossRef
|
|
[10]
|
Duong YT, Kassanjee R, Welte A, Morgan M, De A, Dobbs T, et al. Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes. PLoS One 2015;10(2):e0114947. https://doi.org/10.1371/journal.pone.0114947CrossRef
|
|
[11]
|
Huang XJ, Chen H, Li W, Li HY, Jin X, Perelson AS, et al. Precise determination of time to reach viral load set point after acute HIV-1 infection. J Acquir Immune Defic Syndr 2012;61(4):448 − 54. https://doi.org/10.1097/QAI.0b013e31827146e0CrossRef
|
|
[12]
|
He N, Duan S, Ding YY, Rou KM, McGoogan JM, Jia MH, et al. Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, China. PLoS One 2013;8(11):e77981. https://doi.org/10.1371/journal.pone.0077981CrossRef
|
|
[13]
|
Zhong P. Progress in research and practice of molecular epidemiology of HIV-1. Electron J Emerging Infect Dis 2019;4(3):137 − 44. https://doi.org/10.19871/j.cnki.xfcrbzz.2019.03.003CrossRef
|